Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06296485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safer Aging With Diabetes Monitoring

Study acronym: SAGE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Mar 30, 2027 → Sep 30, 2027
See other at-risk trials from Kaiser Permanente

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Mar 30, 2027 to Sep 30, 2027
    • Study sites: 4 to 6
    v5
  2. Study sites: 3 to 4v4
  3. Interventions: SAGE Group Sessions (Behavioral), SAGE Group Sessions + Diabetes Pharmacist (Behavioral), Usual Care (Other) to SAGE Group Sessions (Behavioral), Usual Care (Other)
    • Study description shortened, about 16 words
    • Study arms: 3 to 2
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 3
    • Start date changed from estimate of Mar 30, 2024 to May 1, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kaiser Permanente
88 trials monitored
See 4 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Trial Details
NCT Number NCT06296485
Lead Sponsor Kaiser Permanente
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2, Hypoglycemia
Related terms Diabetes Mellitus, Type 2, Hypoglycemia
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov